Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 812

1.

A practical algorithm for managing Alzheimer's disease: what, when, and why?

Cummings JL, Isaacson RS, Schmitt FA, Velting DM.

Ann Clin Transl Neurol. 2015 Mar;2(3):307-323. Epub 2015 Jan 23. Review.

2.

A Summary Score for the Framingham Heart Study Neuropsychological Battery.

Downer B, Fardo DW, Schmitt FA.

J Aging Health. 2015 Mar 24. pii: 0898264315577590. [Epub ahead of print]

PMID:
25804903
3.

EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.

Kedmi M, Ben-Chetrit N, Körner C, Mancini M, Ben-Moshe NB, Lauriola M, Lavi S, Biagioni F, Carvalho S, Cohen-Dvashi H, Schmitt F, Wiemann S, Blandino G, Yarden Y.

Sci Signal. 2015 Mar 17;8(368):ra29. doi: 10.1126/scisignal.2005866.

PMID:
25783158
4.

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.

Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR Jr, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, Montine TJ, Nelson PT, Schmitt F, Schneider JA, Serrano-Pozo A, Thal DR, Toledo JB, Trojanowski JQ, Troncoso JC, Vonsattel JP, Wisniewski T.

Acta Neuropathol. 2015 Mar 17. [Epub ahead of print] No abstract available.

PMID:
25778618
5.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C, Dabakuyo-Yonli TS.

Ann Oncol. 2015 Feb 27. pii: mdv106. [Epub ahead of print] Review.

PMID:
25725046
6.

Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.

Cohen-Dvashi H, Ben-Chetrit N, Russell R, Carvalho S, Lauriola M, Nisani S, Mancini M, Nataraj N, Kedmi M, Roth L, Köstler W, Zeisel A, Yitzhaky A, Zylberg J, Tarcic G, Eilam R, Wigelman Y, Will R, Lavi S, Porat Z, Wiemann S, Ricardo S, Schmitt F, Caldas C, Yarden Y.

EMBO Mol Med. 2015 Feb 12;7(3):299-314. doi: 10.15252/emmm.201404134.

7.

Fine Needle Aspiration Cytology of Lobular Breast Carcinoma and Its Variants.

Mucha Dufloth R, Xavier-Júnior JC, Moraes Neto FA, Janoti Dos Santos K, Schmitt F.

Acta Cytol. 2015 Feb 11. [Epub ahead of print]

PMID:
25678304
8.

Interface ferroelectric transition near the gap-opening temperature in a single-unit-cell FeSe film grown on Nb-Doped SrTiO3 substrate.

Cui YT, Moore RG, Zhang AM, Tian Y, Lee JJ, Schmitt FT, Zhang WH, Li W, Yi M, Liu ZK, Hashimoto M, Zhang Y, Lu DH, Devereaux TP, Wang LL, Ma XC, Zhang QM, Xue QK, Lee DH, Shen ZX.

Phys Rev Lett. 2015 Jan 23;114(3):037002. Epub 2015 Jan 22.

PMID:
25659015
9.

Findings from the national memory screening day program.

Bayley PJ, Kong JY, Mendiondo M, Lazzeroni LC, Borson S, Buschke H, Dean M, Fillit H, Frank L, Schmitt FA, Peschin S, Finkel S, Austen M, Steinberg C, Ashford JW.

J Am Geriatr Soc. 2015 Feb;63(2):309-14. doi: 10.1111/jgs.13234. Epub 2015 Jan 30.

PMID:
25643739
10.

The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: An institutional experience.

Rossi ED, Bizzarro T, Schmitt F, Longatto-Filho A.

Cancer Cytopathol. 2015 Jan 14. doi: 10.1002/cncy.21518. [Epub ahead of print]

PMID:
25641902
11.

Thyroid FNA: International perspectives from the European Congress of Cytopathology-Can we cross the bridge of classifications?

Rossi ED, Pusztaszeri M, Schmitt F, Bongiovanni M, Chandra A, Faquin WC.

Cancer Cytopathol. 2015 Jan 14. doi: 10.1002/cncy.21517. [Epub ahead of print] No abstract available.

PMID:
25641880
12.

Neuropeptidomics of the Carpenter Ant Camponotus floridanus.

Schmitt F, Vanselow JT, Schlosser A, Kahnt J, Rössler W, Wegener C.

J Proteome Res. 2015 Mar 6;14(3):1504-14. doi: 10.1021/pr5011636. Epub 2015 Feb 16.

PMID:
25641051
13.

Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort.

Katsumata Y, Mathews M, Abner EL, Jicha GA, Caban-Holt A, Smith CD, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW.

Dement Geriatr Cogn Disord. 2015;39(3-4):215-27. doi: 10.1159/000370108. Epub 2015 Jan 21.

14.

Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease.

McBride JC, Zhao X, Munro NB, Jicha GA, Schmitt FA, Kryscio RJ, Smith CD, Jiang Y.

Neuroimage Clin. 2014 Dec 13;7:258-65. doi: 10.1016/j.nicl.2014.12.005. eCollection 2015.

15.

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Ben-Chetrit N, Chetrit D, Russell R, Körner C, Mancini M, Abdul-Hai A, Itkin T, Carvalho S, Cohen-Dvashi H, Koestler WJ, Shukla K, Lindzen M, Kedmi M, Lauriola M, Shulman Z, Barr H, Seger D, Ferraro DA, Pareja F, Gil-Henn H, Lapidot T, Alon R, Milanezi F, Symons M, Ben-Hamo R, Efroni S, Schmitt F, Wiemann S, Caldas C, Ehrlich M, Yarden Y.

Sci Signal. 2015 Jan 20;8(360):ra7. doi: 10.1126/scisignal.2005537.

PMID:
25605973
16.

Corticothalamic phase synchrony and cross-frequency coupling predict human memory formation.

Sweeney-Reed CM, Zaehle T, Voges J, Schmitt FC, Buentjen L, Kopitzki K, Esslinger C, Hinrichs H, Heinze HJ, Knight RT, Richardson-Klavehn A.

Elife. 2014 Dec 23;3:e05352. doi: 10.7554/eLife.05352.

17.

Sperm cryopreservation in adolescents and young adults with cancer: results of the French national sperm banking network (CECOS).

Daudin M, Rives N, Walschaerts M, Drouineaud V, Szerman E, Koscinski I, Eustache F, Saïas-Magnan J, Papaxanthos-Roche A, Cabry-Goubet R, Brugnon F, Le Lannou D, Barthélémy C, Rigot JM, Fréour T, Berthaut I, Giscard d'Estaing S, Touati F, Mélin-Blocquaux MC, Blagosklonov O, Thomas C, Benhamed M, Schmitt F, Kunstmann JM, Thonneau P, Bujan L.

Fertil Steril. 2015 Feb;103(2):478-86.e1. doi: 10.1016/j.fertnstert.2014.11.012. Epub 2014 Dec 17.

PMID:
25527232
18.

Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study.

Brenner T, Fleming T, Uhle F, Silaff S, Schmitt F, Salgado E, Ulrich A, Zimmermann S, Bruckner T, Martin E, Bierhaus A, Nawroth PP, Weigand MA, Hofer S.

Crit Care. 2014 Dec 12;18(6):683. [Epub ahead of print]

19.

Con: are we ready to translate Alzheimer's disease-modifying therapies to people with down syndrome?

Head E, Schmitt FA.

Alzheimers Res Ther. 2014 Sep 12;6(5-8):61. doi: 10.1186/s13195-014-0061-6. eCollection 2014.

20.

Is thyroid gland only a "land" for primary malignancies? role of morphology and immunocytochemistry.

Diana Rossi E, Martini M, Straccia P, Gerhard R, Evangelista A, Pontecorvi A, Fadda G, Maria Larocca L, Schmitt F.

Diagn Cytopathol. 2014 Nov 26. doi: 10.1002/dc.23241. [Epub ahead of print]

PMID:
25427948
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk